Page 264 - SAHCS HIVMed Journal Vol 20 No 1 2019

Page 8 of 8 Original Research

20. Mahar PD, Wasiak J, Paul E, et al. Comparing mortality outcomes of major burns 38. Mahar PD, Wasiak J, Hii B, et al. A systematic review of the management and
and toxic epidermal necrolysis in a tertiary burns centre. Burns. 2014 Dec;40(8): outcome of toxic epidermal necrolysis treated in burns centres. Burns.
1743–1747. https://doi.org/10.1016/j.burns.2014.03.012 2014;40(7):1245–1254. https://doi.org/10.1016/j.burns.2014.02.006
21. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of 39. Brown KM, Silver GM, Halerz M, Walaszek P, Sandroni A, Gamelli RL.
adverse drug reactions. Clin Pharmacol Ther. 1981 Aug;30(2):239–245. https:// Toxic epidermal necrolysis: Does immunoglobulin make a difference? J Burn
doi.org/10.1038/clpt.1981.154 Care Rehabil. 2004;25(1):81–88. https://doi.org/10.1097/01.BCR.0000105096.
22. Tan A, Tan HH, Lee CC, Ng SK. Treatment of toxic epidermal necrolysis in AIDS with 93526.27
intravenous immunoglobulins. Clin Exp Dermatol. 2003;28(3):269–271. https:// 40. Del Pozzo-Magana BR, Lazo-Langner A, Carleton B, Castro-Pastrana LI, Rieder MJ.
doi.org/10.1046/j.1365-2230.2003.01255.x A systematic review of treatment of drug-induced Stevens-Johnson syndrome
23. Singh H, Kachhap VK, Kumar BN, Nayak K. Nevirapine induced Stevens-Johnson and toxic epidermal necrolysis in children. J Popul Ther Clin Pharmacol.
syndrome in an HIV infected patient. Indian J Pharmacol. 2011 Feb;43(1):84–86. 2011;18:e121–e133.
https://doi.org/10.4103/0253-7613.75680 41. Knight L, Muloiwa R, Dlamini S, Lehloenya RJ. Factors associated with increased
24. Pacheco H, Araujo T, Kerdel F. Toxic epidermal necrolysis in a pregnant, HIV-infected mortality in a predominantly HIV-infected population with Stevens Johnson
woman. Int J Dermatol. 2002;41(9):600–601. https://doi.org/10.1046/ j.1365- syndrome and toxic epidermal necrolysis. PLoS One. 2014;9(4):e93543. https://
4362.2002.01554.x doi.org/10.1371/journal.pone.0093543
25. Pahk R, Azu MC, Taira BR, Sandoval S. Antiretroviral-induced toxic epidermal 42. Harr T, French LE. Toxic epidermal necrolysis and Stevens-Johnson syndrome.
necrolysis in a patient positive for human immunodeficiency virus. Clin Exp Orphanet J Rare Dis. 2010;5:39. https://doi.org/10.1186/1750-1172-5-39
Dermatol. 2009 Dec;34(8):e775–e777. https://doi.org/10.1111/j.1365-2230.2009. 43. Weinand C, Xu W, Perbix W, et al. 27 years of a single burn centre experience with
03508.x Stevens-Johnson syndrome and toxic epidermal necrolysis: Analysis of mortality
26. Stella M, Clemente A, Bollero D, Risso D, Dalmasso P. Toxic epidermal necrolysis risk for causative agents. Burns. 2013;39(7):1449–1455. https://doi.org/10.1016/j.
(TEN) and Stevens–Johnson syndrome (SJS): Experience with high-dose burns.2013.03.011
intravenous immunoglobulins and topical conservative approach: A retrospective 44. De Prost N, Ingen-Housz-Oro S, Duong T, et al. Bacteremia in Stevens-Johnson
analysis. Burns. 2007;33(4):452–459. https://doi.org/10.1016/j.burns.2006. syndrome and toxic epidermal necrolysis: Epidemiology, risk factors, and
08.014 predictive value of skin cultures. Medicine. 2010 Jan;89(1):28–36. https://doi.
27. Hirahara K, Kano Y, Sato Y, et al. Methylprednisolone pulse therapy for Stevens- org/10.1097/MD.0b013e3181ca4290
Johnson syndrome/toxic epidermal necrolysis: Clinical evaluation and analysis of 45. Schwartz RA, McDonough PH, Lee BW. Toxic epidermal necrolysis: Part II.
biomarkers. J Am Acad Dermatol. 2013;69(3):496–498. https://doi.org/10.1016/j. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment.
jaad.2013.04.007 J Am Acad Dermatol. 2013 Aug;69(2):187.e1–187.e16. https://doi.org/10.1016/j.
28. Patterson R, Miller M, Kaplan M, et al. Effectiveness of early therapy with jaad.2013.05.002
corticosteroids in Stevens-Johnson syndrome: Experience with 41 cases and a 46. Araki Y, Sotozono C, Inatomi T, et al. Successful treatment of Stevens-Johnson
hypothesis regarding pathogenesis. Ann Allergy. 1994 Jul;73(1):27–34. syndrome with steroid pulse therapy at disease onset. Am J Ophthalmol.
29. Kakourou T, Klontza D, Soteropoulou F, Kattamis C. Corticosteroid treatment of 2009;147(6):1004–1011.e1. https://doi.org/10.1016/j.ajo.2008.12.040
erythema multiforme major (Stevens-Johnson syndrome) in children. Eur J 47. Kim KH, Park SW, Kim MK, Wee WR. Effect of age and early intervention with
Pediatr. 1997 Feb;156(2):90–93. https://doi.org/10.1007/s004310050561 a systemic steroid, intravenous immunoglobulin or amniotic membrane
30. Tripathi A, Ditto AM, Grammer LC, et al. Corticosteroid therapy in an additional transplantation on the ocular outcomes of patients with Stevens-Johnson syndrome.
13 cases of Stevens-Johnson syndrome: A total series of 67 cases. Allergy Asthma Korean J Ophthalmol KJO. 2013 Oct;27(5):331–340. https://doi.org/10.3341/kjo.
2013.27.5.331
Proc. 2000 Mar–Apr;21(2):101–105. https://doi.org/10.2500/108854100778
250914 48. Govender I, Mabuza HL, Ogunbanjo GA. The characteristics of HIV and AIDS
31. Hynes AY, Kafkala C, Daoud YJ, Foster CS. Controversy in the use of high-dose patients with deep vein thrombosis at Dr. George Mukhari Academic Hospital. Afr
J Prim Health Care Fam Med. 2015 Mar 27;7(1). https://doi.org/10.4102/phcfm.
systemic steroids in the acute care of patients with Stevens-Johnson syndrome. v7i1.690
Int Ophthalmol Clin. 2005;45(4):25–48. https://doi.org/10.1097/01.iio.0000177
430.89645.6d 49. Momin SB. Review of intravenous immunoglobulin in the treatment of Stevens-
32. Schneck J, Fagot J-P, Sekula P, Sassolas B, Roujeau JC, Mockenhaupt M. Effects of Johnson syndrome and toxic epidermal necrolysis. J Clin Aesthet Dermatol.
2009;2(2):51–58.
treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal
necrolysis: A retrospective study on patients included in the prospective EuroSCAR 50. Colman-Brochu S. Deep vein thrombosis in pregnancy. MCN Am J Matern
Study. J Am Acad Dermatol. 2008;58(1):33–40. https://doi.org/10.1016/j.jaad. Child Nurs. 2004 May–Jun;29(3):186–192. https://doi.org/10.1097/00005721-
2007.08.039 200405000-00010
33. Rasmussen JE. Erythema multiforme in children. Response to treatment with 51. Bera E, Mia R. Safety of nevirapine in HIV-infected pregnant women initiating
systemic corticosteroids. Br J Dermatol. 1976 Aug;95(2):181–186. https://doi. antiretroviral therapy at higher CD4 counts: A systematic review and meta-
org/10.1111/j.1365-2133.1976.tb00824.x analysis. S Afr Med J. 2012 Oct 8;102(11 Pt 1):855–859. https://doi.org/10.7196/
34. Halebian PH, Corder VJ, Madden MR, Finklestein JL, Shires GT. Improved burn SAMJ.5700
center survival of patients with toxic epidermal necrolysis managed without 52. Dube N, Adewusi E, Summers R. Risk of nevirapine-associated Stevens-Johnson
corticosteroids. Ann Surg. 1986 Nov;204(5):503–512. https://doi.org/10.1097/ syndrome among HIV-infected pregnant women: The Medunsa National
00000658-198611000-00001 Pharmacovigilance Centre, 2007–2012. S Afr Med J. 2013 May;103(5):322–325.
35. Aberdein J, Singer M. Clinical review: A systematic review of corticosteroid use in https://doi.org/10.7196/SAMJ.6077
infections. Critical Care. 2006;10(1):203. https://doi.org/10.1186/cc3904 53. Tiwari P, Panik R, Bhattacharya A, Ahirwar D, Chandy A. Toxic epidermal necrolysis:
36. Mayosi BM, Ntsekhe M, Bosch J, et al. Rationale and design of the investigation of An update. Asian Pac J Trop Dis. 2013;3(2):85–92. https://doi.org/10.1016/S2222-
the management of pericarditis (IMPI) trial: A 2 x 2 factorial randomized double- 1808(13)60051-1
blind multicenter trial of adjunctive prednisolone and Mycobacterium w 54. Yang C, Mosam A, Mankahla A, Dlova N, Saavedra A. HIV infection predisposes
immunotherapy in tuberculous pericarditis. Am Heart J. 2013 Feb;165(2):109. skin to toxic epidermal necrolysis via depletion of skin-directed CD4 T cells. J Am
e3–115.e3. Acad Dermatol. 2014 Jun;70(6):1096–1102. https://doi.org/10.1016/j.jaad.2013.
37. Jagadeesan S, Sobhanakumari K, Sadanandan SM, et al. Low dose intravenous 12.025
immunoglobulins and steroids in toxic epidermal necrolysis: A prospective 55. Marks DJ, Dheda K, Dawson R, Ainslie G, Miller RF. Adverse events to
comparative open-labelled study of 36 cases. Indian J Dermatol Venereol Leprol. antituberculosis therapy: Influence of HIV and antiretroviral drugs. Int J STD AIDS.
2013 Jul–Aug;79(4):506–511. https://doi.org/10.4103/0378-6323.113080 2009 May;20(5):339–345. https://doi.org/10.1258/ijsa.2008.008361

http://www.sajhivmed.org.za 257 Open Access